Solamargine (SM) has been shown to have anti-cancer properties. However, the underlying mechanism involved remains undetermined. We showed that SM inhibited the growth of non-small cell lung cancer (NSCLC) cells, which was enhanced in cells with silencing of long non-coding RNA (lncRNA) HOX transcript antisense RNA (HOTAIR), while it overcame by overexpression of HOTAIR. In addition, SM increased the expression of miR-214-3p and inhibited 3-phosphoinositide-dependent protein kinase-1 (PDPK1) gene expression, which was strengthened by miR-214-3p mimics.
initiation and progression as well as therapeutics attributable to better treatment outcomes. However, despite these improvements, the 5-year survival rate has shown little or no change. 1, 2 Thus, there is a greater need to search for alternative and novel therapeutic modalities which will enhance the treatment efficacy in lung cancer patients.
Natural phytochemicals derived from medicinal plants have gained significant recognition in the control of carcinogenesis and are considered as a novel approach in the prevention and treatment of cancer. Solamargine (SM), a natural glycoalkaloid extracted from the fruits of Solanum lycocarpum, has been shown to be effective against several types of cancers. [3] [4] [5] [6] It induced apoptosis via the mitochondrial pathway and altered the level of apoptosis-associated proteins in human cholangiocarcinoma cells. 4 SM caused the suppression of lung cancer cell growth in vitro and in vivo by increasing insulin-like growth factor binding protein 1 (IGFBP1) expression through activation of the signal transducer and activator of transcription 3 (Stat3)/SP1/forkhead box O3a (FOXO3a) axis pathways. 7 In addition, we have previously reported that SM can inhibit the growth of prostate cancer cells via AMPactivated protein kinase (AMPK) α-mediated inhibition of p65 and cell surface-associated mucin 1 (MUC1) in vitro and in vivo. 8 Regardless, the detailed mechanism underlying the anti-lung cancer effects of SM remains to be elucidated.
Long non-coding RNAs (lncRNAs) are key modulators of various pathological processes in human cancers. Among these, the oncogenic HOX transcript antisense intergenic RNA (HOTAIR), an approximately 2.2 kb lncRNA transcribed from the HOXC locus, is reported to be associated with growth and invasion of several types of cancer. [9] [10] [11] [12] HOTAIR stimulated the migration and invasion of cervical cancer cells through miR-206-mediated regulation of transcription of the megakaryoblastic leukaemia 1 (MKL1). 10 In addition, HOTAIR has been postulated to represent a biomarker of lung cancer because its upregulation positively correlates with metastasis, drug resistance and poor survival in lung cancer patients. 13 Thus, HOTAIR is considered as a potential biomarker and therapeutic target in cancers. [13] [14] [15] Nevertheless, the potential associations and the exact role of HOTAIR in lung cancer still remain undetermined.
Dysregulation of miRNA is associated with an increasing number of human diseases including cancer. 16 Among these, miR-214-3p has been reported to be associated with growth, progression and survival in cancers. [17] [18] [19] [20] miR-214-3p inhibited proliferation and cell cycle progression by targeting maternal embryonic leucine zipper kinase (MELK), also known as an oncogenic kinase and a key regulator in the malignancy and proliferation of cancer. 21 Induced expression of miR-214-3p in oesophageal cancer cells resulted in a decrease in the expressions of survivin and CUG binding protein 1 (CUG-BP1), an RNA-binding protein, resulting in enhanced sensitivity of oesophageal cancer cells to cisplatin. 22 The above results highlight the importance of miR-214-3p in cancer initiation and progression, suggesting that modulation of miR-214-3p may be a key therapeutic target for miRNAbased cancer therapies. 23 However, the role of miRNAs in the biology of lung cancer still remains unclear.
As a common upstream activator, 3-phosphoinositide-dependent protein kinase-1 (PDPK1) activates multiple downstream effectors and promotes the development of various diseases including cancer. 24, 25 Pharmacologic and genetic inhibition of PDPK1 resulted in the regression of tumour growth in vitro and attenuated the tumorigenesis in tumour models in vivo. [26] [27] [28] Thus, PDPK1 may represent a novel and rational therapeutic candidate for preventing cancer. [29] [30] [31] Of note, there are only limited numbers of studies demonstrating the link between miR-214-3p, HOTAIR and PDPK1. Therefore, a gap exists in our understanding of the role of this interaction in lung cancer.
Herein, we extended these studies and found that SM inhibited the growth of human lung cancer cells by suppressing PDPK1 expression through a reciprocal interaction between HOTAIR and miR-214-3p. 
| MATERIAL S AND ME THODS

| Reagents and cell cultures
| Cell viability assay
The 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to measure the cell viability as described previously. 32 NSCLC cells (5 × 10 3 cells/well) were counted and seeded into 96-well microtiter plates, and treated with indicated doses of SM for up to 72 hours. After adding MTT solution (5 mg/mL), plates were incubated at 37°C for 4 hours followed by the addition of dimethyl sulfoxide. Absorbance was measured at 570 nm on a microplate reader (Perkin Elmer, Victor X5). Cell viability was calculated as the ratio of absorbance of sample/control. The cells treated with vehicle only (0.1% DMSO) served as a negative control and the control values were set to 1 by default.
| EdU assay for cell proliferation
Non-small cell lung cancer cell proliferation was assessed by Cell-Light EdU Apollo 488 In Vitro Imaging Kit (RiboBio) according to instructions from the manufacturer. Briefly, after treatment with SM in 96-well plates for 24 hours, the cells were incubated with EdU reagent for 2 hours and fixed in 4% paraformaldehyde for 30 minutes.
Thereafter, cells were washed in glycine and incubated in 0.2% Trion X-100 for 10 minutes followed by the addition of 1× Apollo reaction buffer. After washing in 0.5% Triton X-100, the cells were stained with Hoechst (5 mg/mL). Images were taken under a BX53+DP72 Microscope (Olympus Corporation) and evaluated by Image-Pro plus 6.0 image analysis software (Media Cybernetics, Inc). Per cent cell proliferation was calculated as: (EdU positive cells/Hoechst stained cells) × 100.
| Flow cytometric analysis
Cell apoptosis was detected using Annexin V-FITC/PI Apoptosis Detection Kit (BD Biosciences) according to the manufacturer's protocol. Briefly, the cells were treated with SM for 24 hours, washed with pre-cooled phosphate-buffered saline (PBS), and mildly trypsinized without the use of EDTA. Subsequently, the cells were harvested, resuspended in 500 μL of the binding buffer and incubated with 5 μL Annexin V-FITC reagent for 15 minutes and 10 μL PI for 5 minutes at room temperature (RT) in the dark. Cell apoptosis was measured by flow cytometry (FC500, Beckman Coulter), and data were analysed by GraphPad Prism 5.0 software.
| Cell invasion assay
The potential invasiveness of lung cancer cells was assessed using transwell plates with 10 mm diameter and 8 μm pore size polycarbonate membrane coated with a film of Matrigel (BD Biosciences) as reported previously. 33 The upper compartment was seeded with 0.5 × 10 6 cells and treated with or without SM. The lower compartment was filled with culture medium. After 24 hours incubation, non-migrated cells were removed and migrated cells were fixed in 4% paraformaldehyde, and stained with crystal violet. Stained cells were counted and images were taken under Ts2RFL microscope (Nikon). The number of invaded cells is represented as percentage of control. 
| Quantitative real-time RT-PCR
| Determination of amplification efficiency
Reverse-transcribed cDNA was diluted by 5 10-fold serial dilutions.
qRT-PCR was performed to detect the expression of HOTAIR and miR-214-3p with the corresponding primers, and each sample was processed three times. A standard curve was generated by plotting the log values of dilution multiples on the X-axis and the corresponding CT values on the Y-axis. The amplification efficiency of the primers, E, was calculated as: E = 10 −1/slope −1. The amplification efficiency in the range from 90% to 110% is generally considered to be adequate. Our results showed that amplification efficiency for HOTAIR and miR-214-3p was 100.99% and 100.34%, respectively.
| Western blot analysis
Equal amounts of protein from whole cell lysates were dissolved in SDS-sample buffers and separated on 10% SDS polyacrylamide gels. Membranes (Millipore) were incubated with antibodies against PDPK1 for 2 hours, washed and incubated with secondary rabbit IgG antibody conjugated to horseradish peroxidase (Cell Signaling Technology). The membranes were washed again and transferred to a freshly prepared enhanced chemiluminescence solution (Immobilon Western; Millipore). Protein bands were observed using the Gel Imagine System (Bio-Rad). ImageJ software (National Institutes of Health) was used to quantify and compare the intensity of single band between the control and proteins of interest.
| Transient transfection assays
Cells were seeded in 6-well or 96-well culture plates and grown to 60% confluency before transfection with the control or HOTAIR 
| Luciferase reporter assay
The binding sites of HOTAIR and PDPK1 for miR-214-3p were obtained using bioinformatics prediction databases (TargetScan, http:// www.targe tscan.org/vert_72/, MiRBase, http://www.mirba se.org/, and MiRWalk http://mirwa lk.umm.uni-heide lberg.de/). 3′-UTR cDNA fragment of PDPK1 containing the wild-type and mutated miR-214-3p binding sites, named pEZX-MT05-Luc-PDPK1-WT or pEZX-MT05-Luc-PDPK1-Mut and 3′-UTR cDNA fragments of HOTAIR containing the wild-type and mutated miR-214-3p binding sites, named pEZX-MT05-Luc-HOTAIR-WT or pEZX-MT05-Luc-HOTAIR-Mut were ordered from GeneCopoeia, Inc. The cells were transfected with the plasmids (1.25 μg/mL each) for 24 hours using Lipofectamine 3000 reagent and then treated with miR-214-3p mimics for an additional 48 hours. The preparation of cell extracts and measurement of luciferase activities were done by using Secrete-Pair Dual Luminescence Assay Kit (GeneCopoeia, Inc) and were normalized with SEAP activity within each sample.
| Cell immunofluorescence
Cells were fixed in paraformaldehyde and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) followed by incubation in normal goat serum for 30 minutes, and incubation with anti-human PDPK1 antibody (1:100) overnight. After washing, the cells were incubated with secondary anti-Rabbit IgG (H+L) antibody conjugated to Alexa Fluor 594 (A21442, Invitrogen, ThermoFisher) followed by washing and counterstaining with DAPI. Slides were mounted with FluorSave (Calbiochem). Fluorescence was detected under an Axio Observer Z1 immunofluorescence microscope (Carl Zeiss Inc).
| RNA immunoprecipitation (RIP) assay
RNA immunoprecipitation (RIP) assay was performed using the Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore) following instruction from the manufacturer. Briefly, after washing in PBS, the cells were lysed in RNA lysis buffer containing RNase inhibitor. The cells lysates were incubated with magnetic beads coated with the specific PDPK1 antibody (Abcam), anti-Ago2 antibody (Millipore) or the negative control IgG (Millipore). Finally, the expression of HOTAIR, miR-214-3p, PDPK1 and Ago2 was measured by qRT-PCR as well as Western blot.
| Xenograft tumours and bioluminescent imaging
Animal studies were performed according to the protocols ap- were maintained at the Animal Center of Guangdong Provincial Hospital of Chinese Medicine. A549-Luc or A549PDPK1+/+-Luc (2 × 10 6 ) were injected subcutaneously into the nude mice.
Xenografts were allowed to grow when the initial measurements were made with calipers. For bioluminescence imaging (BLI), mice were anesthetized by inhalation of 2% isoflurane. The substrate D-luciferin (Caliper Life Sciences) was injected into the peritoneal cavity of the mice at a dose of 150 mg/kg. The intensity of the BLI signal was determined using the IVIS-200 Imaging System (Xenogen/Caliper). Mice were then randomly divided into the control and SM groups (n = 10/group), and SM was injected intraperitoneally daily at a dose of 8 mg/kg for up to 25 days based on our previous reports and others, 7, 34, 35 which showed significant inhibitory effect of SM on tumour growth without apparent toxicity.
Tumour volume was calculated using the formula for a spheroid: 
| Statistical analysis
All in vitro experiments were performed at least three times.
Statistical analysis was carried out using GraphPad Prism version 5.04 for Windows (GraphPad Software). Pair wise comparisons were done by paired two-tailed t test, Mann-Whitney test or Fisher exact test. The data in most graphs are presented relative to the control. P values <.05 were considered significant.
| RE SULTS
| SM-inhibited proliferation of NSCLC cells via inhibition of HOTAIR
Previous reports showed that SM significantly inhibited the growth of NSCLC cells via several mechanisms. 7, 34 In the current study, we demonstrated that percentage of EdU positive NSCLC cells was significantly reduced in the SM-treated group compared with the control group ( Figure 1A 
| SM increased miR-214-3p expression in NSCLC cells
To further dissect the mechanism of the inhibitory effect of SM on lung cancer cells, we searched for potential miRNAs that may link HOTAIR and other target genes. We observed reduced transcript abundance of miR-214-3p in A549 and PC9 cells compared with normal human bronchial epithelial cell (BEAS-2B; Figure 2A ), however, in the presence of SM there was a significant increase in expression of miR-214-3p ( Figure 2B ). Furthermore, miR-214-3p mimics significantly inhibited the growth and invasiveness of A549 and PC9 cells as compared with the control group ( Figure 2C,D) .
These results confirmed that miR-214-3p functions as a tumour suppressor role and suggested that miR-214-3p may enhance the SM-mediated inhibition of NSCLC cell growth. 
| Interaction between HOTAIR and miR-214-3p was involved in SM-inhibited cell growth
Next, we began to test the biological significance of the interaction between HOTAIR and miR-214-3p in mediating the effect of SM. Results showed that the expression of miR-214-3p was significantly higher in cells with silenced HOTAIR compared with the control siRNA-transfected cells ( Figure 3A) . Conversely, mimics of miR-214-3p had no effect on HOTAIR expression ( Figure 3B ).
Moreover, we found that silencing HOTAIR further strengthened SM-induced miR-214-3p expression ( Figure 3C ), while overexpression of HOTAIR reversed SM-induced miR-214-3p expression ( Figure 3D ).
By utilizing bioinformatics prediction databases, we found that miR-214-3p has a classical and conservative binding site in the 3′-UTR region of HOTAIR ( Figure 3E ). We generated a 3′-UTR cDNA fragment of HOTAIR containing the wild-type and mutated miR-214-3p binding sites ( Figure 3E ). We found that the interaction of miR-214-3p with the wild-type 3′-UTR cDNA fragment of HOTAIR significantly decreased the luciferase activities of HOTAIR in A549 and PC9 cells compared with the negative control group ( Figure 3E ) suggesting a direct inhibitory effect of miR-214-3p on HOTAIR expression. Furthermore, RIP assay showed that Ago2 protein was successful pulled down by Ago2 antibody-coated magnetic beads ( Figure 3F ). And qRT-PCR analysis revealed that both HOTAIR and miR-214-3p were enriched in the Ago2-containing beads and were higher compared with the input group ( Figure 3F) . Moreover, the physical binding of HOTAIR to miR-214-3p was also significantly affected in the presence of SM ( Figure 3F ). These results suggested that the physical interaction between HOTAIR and miR-214-3p may also play an additional role in mediating the anti-carcinogenic effect of SM.
| SM-inhibited PDPK1 expression via correlation and interaction of HOTAIR and miR-214-3p
Previously, we demonstrated an important role of PDPK1 in cancer growth with the implication that targeting PDPK1 may be a potential treatment of lung cancer. 33, 37 In line with this, overexpression of PDPK1 in A549PDPK1+/+-Luc cells not only showed more growth regression, it also significantly resisted the SM-inhibited growth as compared with the wild-type A549-Luc cells ( Figure 4A ). Both
Western blot and immunofluorescence confirmed that SM reduced PDPK1 protein expression ( Figure 4B,C) .
In order to validate our findings and further identify the relevant targets of HOTAIR and miR-214-3p association, we treated the NSCLC cells with miR-214-3p mimics and determined PDPK1 protein expression. Results showed that miR-214-3p mimics reduced whereas miR-214-3p inhibitors increased PDPK1 protein expression ( Figure 5A,B) . While over-expressing miR-214-3p had no effect, silencing HOTAIR resulted in decreased PDPK1 promoter activity ( Figure 5C,D) . Note that the latter also suppressed PDPK1 protein expression ( Figure 5E ). Together, these results suggested that while miR-214-3p may regulate PDPK1 post-transcriptionally, HOTAIR may regulate both transcriptionally and translationally.
To further delineate the functional role of miR-214-3p and whether PDPK1 is its downstream target, we searched bioinformatics prediction databases and found a classical and conservative binding site for miR-214-3p in 3′-UTR region of PDPK1 ( Figure 5F ). We observed that the binding of miR-214-3p mimics to the wild-type 3′-UTR cDNA fragment of PDPK1 significantly reduced the luciferase activity in comparison with the mutated 3′UTR or negative control/ scrambled mimics ( Figure 5F ).
The results suggested that PDPK1 is a downstream target of miR-214-3p.
Finally, RIP assay demonstrated a physical interaction between HOTAIR and PDPK1 protein which was inhibited by SM ( Figure 5G ). These results suggested that SM exerts its effect on the interaction between HOTAIR and PDPK1 protein by suppressing PDPK1 expression. 
| Overexpression of PDPK1 neutralized the effect of SM on HOTAIR and miR-214-3p expressions, and cell growth
In order to confirm the role PDPK1 in the interaction of HOTAIR and miR-214-3p, we showed that overexpression of PDPK1 neutralized the effects of SM on miR-214-3p, but not HOTAIR, expression ( Figure 6A,B ).
In addition, overexpressed PDPK1 overcame the SM-inhibited growth in NSCLC cells ( Figure 6C ). Together, the findings indicate the presence of a feedback loop between PDPK1 and miR-214-3p, and the interactive regulatory axis among HOTAIR, miR214-3p and PDPK1 contributing to the inhibitory activity of SM on growth of NSCLC cells.
| SM-inhibited tumour growth and regulated the expressions of HOTAIR, miR-214-3p and PDPK1 in vivo
We used A549-Luc and A549-PDPK1 (+/+)-Luc cells to examine whether overexpression of PDPK1 resisted the effect of SM on tumour growth in vivo. We found that SM significantly inhibited tumour growth ( Figure 7A ). However, the inhibitory effect was reduced with A549-PDPK1 (+/+)-Luc cells ( Figure 7A ). In addition, SM caused sig- anti-cancer properties. 4, 5, 38 Studies from our and other laboratories have demonstrated that SM inhibits the growth of cancer cells including lung by regulating several molecules and signalling pathways. 4, [34] [35] [36] 38 We recently found that atractylenolide 1, one of major bioactive compounds of Atractylodis macrocephalae, inhibited growth of lung cancer cells through ERK1/2-mediated suppression of Stat3 and SP1, resulting in inhibition of PDPK1 gene expression. 37 It is well known that RNA species, such as lncRNAs and miRNAs, are extensively studied because of their function as gene regulators in both normal biological and pathological processes, such as tumorigenesis. 39 In the current study, we provided new evidence on a reciprocal inter-regulation between the lncRNA HOTAIR and miR-214-3p. These interactions contribute to the inhibition of PDPK1 expression, and, together with a feedback regulatory axis, synergistically enhance the overall anti-lung cancer effect of SM. 
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We demonstrated a role of HOTAIR in the SM-mediated inhibition of lung cancer cell growth. Aberrant increase in HOTAIR expression is positively correlated with growth, progression, drug resistance, recurrence and poor prognosis; all of which are mediated by regulation of several downstream targets through multiple signalling pathways. [40] [41] [42] Our results confirmed that HOTAIR is an important target gene of SM in lung cancer cells and that inhibition of HOTAIR by SM is involved in the inhibition of NSCLC cell growth.
In line with this, HOTAIR was highly expressed in NSCLC cells and involved in cell migration, growth, invasion and metastasis. 13, [43] [44] [45] The aberrant HOTAIR expression is expected to be considered as a potential biomarker for patients with NSCLC. 46 We also observed the critical role of miR-214-3p as a tumour suppressor in mediating the effect of SM on NSCLC cell growth. MiR-214-3p has been reported to be involved in several biological functions and associated with growth, apoptosis, progression and survival. [17] [18] [19] This shows that miR-214-3p may be a key therapeutic target for miRNA-based therapies for cancer. 23 In addition, HOTAIR also affects the miR-NAs-mediated suppression of target gene expression by competitive binding to miRNAs. Our findings suggested that not only the regulation but also the reciprocal and physical interaction between HOTAIR and miR-214-3p in the presence of SM might be involved in the anti-lung cancer effect of SM. A limited number of studies have shown the interaction of HOTAIR with miRNAs in influencing cancer cell growth, 47, 48 and one study reported the link between HOTAIR and miR-214-3p. 49 This unravelled a novel mechanism underlying the anti-cancer effect of SM. HOTAIR may also act as a ceRNA for miRNAs thereby modulating the endogenous target gene expression and subsequent pathways in cancer cell growth. 48, 50 Future studies are required to test and confirm the role of HOTAIR in primary cells of NSCLC. Of note, the physical binding of HOTAIR to miR-214-3p affected in the presence of SM was not strong, in particular in A549 cells, although the statistical difference was observed. We believe that the true significance of this association and the details of the underlying mechanism need to be determined in the future. PDPK1, a master regulatory protein kinase and a member of the AGC protein kinase family, activates multiple downstream effectors implicated in various diseases including cancer. 24 Inhibition of PDPK1 reduced proliferation and progression and attenuated tumorigenesis in vivo in several tumour models. [26] [27] [28] Our results showed that, while A549 cells with stably expressing PDPK1 showed more aggressive growth, overexpression of PDPK1 significantly countered the inhibitory effects of SM indicating and confirming the tumorogenic properties of this molecule. Furthermore, our result implied that PDPK1 was regulated post-transcriptionally by miR-214-3p and both transcriptionally and translationally by HOTAIR. As miRNAs regulate their target genes by binding to the 3′-UTR resulting in either mRNA degradation or inhibition of translation, 51, 52 we established that miR-214-3p directly inhibited PDPK1 gene expression by binding to specific sequences in 3′-UTR. Limited studies have demonstrated F I G U R E 6 Overexpression of PDPK1 neutralized the effect of SM on HOTAIR and miR-214-3p expressions, and cell growth. A-C, A549 and PC9 cells were transfected with the control or overexpressed PDPK1 vector for 24 h before exposure of the cells to SM (6 μmol/L) for an additional 24 h. Afterwards, the expression of HOTAIR, miR-214-3p, and cell growth was measured via qRT-PCR and MTT assays as described in the Materials and Methods section, respectively. Values in bar graphs were given as the mean ± SD from three independent experiments. *Indicates significant difference as compared to the untreated control group (P < .05). **Indicates significant difference from the SM alone (P < .05) the association and interaction between miR-214-3p, HOTAIR and PDPK1. Our findings indicated that both miR-214-3p and HOTAIR act as upstream regulators of PDPK1 gene expression in the presence of SM in lung cancer cells. In addition, SM reduced HOTAIR binding to PDPK1 protein implying that this interaction could lead to a reduction of genes, including PDPK1 that may be involved in the effect of SM in anti-lung cancer effects. Together, our results suggested that HOTAIR may function as a competing endogenous RNA and sequester miR-214-3p from its target gene, PDPK1. These novel interactions and correlations unveiled a previously unknown mechanism underlying the anti-carcinogenic effect of SM in lung cancer.
The alignment of the in vivo results with the in vitro observations further confirms that the inhibitory effects of SM on lung tumour growth are mediated through the interaction and feedback regulatory axis of miR-214-3p, HOTAIR and PDPK1. The doses of SM used were based on our previous reports 8, 34 and another study, 35 which showed significant inhibitory effects on tumour growth without noticeable toxicity. Our findings suggested that SM-inhibited human lung cancer cell growth via inhibition of the PDPK1 and HOTAIR, and induction of miR-214-3p signalling axis.
In summary, our results show that SM inhibits NSCLC cell growth through reciprocal interaction between HOTAIR and miR-214-3p.
This complex interaction of HOTAIR and miR-214-3p, and the regulatory feedback axis contribute to the overall anti-lung cancer effects of SM in vitro and in vivo ( Figure 7H ). These findings improve our understanding of the underlying mechanisms involved in the anti-cancer effect of SM and provide novel molecular targets for the treatment of human lung cancer. 
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